Helvet Health awarded Incyte rare blood cancer brand across Europe

Incyte, an innovative and patient-focused biotech company, selected Helvet Health earlier this year to support the re-branding efforts of a leading treatment in rare blood cancers.

Helvet Health worked to redefine the brand positioning, messaging and entire creative universe, to create more impactful and consistent brand communications across Europe.

How we can help you?